Who owns ARROWHEAD PHARMACEUTICALS IN NOTE 1/1?
- CUSIP Number: 04280aac4
Tip: Access positions for across all investors
Analyze quarterly positions in Arrowhead Pharmaceuticals In Note 1/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arrowhead Pharmaceuticals In Note 1/1 stock
Who bought or sold ARROWHEAD PHARMACEUTICALS IN NOTE 1/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 200M | $207M | 100% | Mar 2026 |
|
| Linden Advisors | 92M | $96M | 100% | Mar 2026 |
|
| Camden Asset Management | 46M | $47B | 100% | Mar 2026 |
|
| LMR Partners | 35M | $36M | 100% | Mar 2026 |
|
| Readystate Asset Management | 25M | $26M | 100% | Mar 2026 |
|
| Calamos Advisors | 23M | $24M | 100% | Mar 2026 |
|
| Jump Financial | 19M | $19M | 100% | Mar 2026 |
|
| Context Capital Management | 15M | $16M | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 14M | $15M | 100% | Mar 2026 |
|
| State Street Corporation | 14M | $14M | 100% | Mar 2026 |
|
| Oaktree Capital Management | 11M | $12M | 100% | Mar 2026 |
|
| Polar Securities | 10M | $10M | 100% | Mar 2026 |
|
| Lazard Asset Management | 8.8M | $92k | 100% | Mar 2026 |
|
| Shenkman Capital Management | 8.7M | $9.2B | 100% | Mar 2026 |
|
| Point72 Asset Management | 7.8M | $8.1M | 100% | Mar 2026 |
|
| FMR | 7.2M | $7.4M | 100% | Mar 2026 |
|
| SSI Investment Management | 6.6M | $6.8M | 100% | Mar 2026 |
|
| Ing Investment Management | 5.3M | $5.5M | 100% | Mar 2026 |
|
| UBS Group | 4.2M | $4.3M | 100% | Mar 2026 |
|
| Citigroup | 3.5M | $3.6M | 100% | Mar 2026 |
|
| Millennium Management | 3.4M | $3.5M | 100% | Mar 2026 |
|
| Invesco | 3.3M | $3.4M | 100% | Mar 2026 |
|
| Amundi | 3.1M | $3.1k | 100% | Mar 2026 |
|
| MacKay Shields | 3.0M | $3.1M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 3.0M | $3.1M | 100% | Mar 2026 |
|
| State of Wisconsin Investment Board | 3.0M | $3.1M | 100% | Mar 2026 |
|
| Braidwell | 2.3M | $2.3M | 100% | Mar 2026 |
|
| Gabelli Funds | 2.1M | $2.3M | 100% | Mar 2026 |
|
| Tenor Capital Management | 2.0M | $2.1M | 100% | Mar 2026 |
|
| Franklin Resources | 1.7M | $1.7M | 100% | Mar 2026 |
|
| Acasta Partners UK | 1.5M | $1.8M | 275% | Jun 2026 |
|
| Jane Street | 1.5M | $1.6M | 100% | Mar 2026 |
|
| RWC Asset Management | 1.4M | $1.4M | 100% | Mar 2026 |
|
| Agf Management | 1.3M | $1.3M | 100% | Mar 2026 |
|
| Bank of New York Mellon | 1.2M | $1.3M | 100% | Mar 2026 |
|
| Ares Systematic Credit | 1.0M | $991k | 100% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.0M | $1.0M | 100% | Mar 2026 |
|
| Groupama Asset Managment | 1.0M | $991k | 100% | Mar 2026 |
|
| Davidson Kempner Capital Management | 1.0M | $1.0M | 100% | Mar 2026 |
|
| Toronto-Dominion Bank | 953k | $984k | 100% | Mar 2026 |
|
| Man Group | 950k | $984k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 860k | $891k | 100% | Mar 2026 |
|
| Kohlberg Kravis Roberts & Co | 800k | $830k | 100% | Mar 2026 |
|
| Morgan Stanley | 695k | $719k | 100% | Mar 2026 |
|
| Bank of America Corporation | 500k | $517k | 100% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 342k | $408k | 100% | Jun 2026 |
|
| Loomis, Sayles and | 172k | $11M | 100% | Mar 2026 |
|
| Sei Investments | 32k | $33k | 100% | Mar 2026 |
|
| Nomura Holdings | 14k | $875k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 10k | $1.0M | 100% | Mar 2026 |
|
| SG Americas Securities | 6.9k | $715k | 100% | Mar 2026 |
|